 44.3% of the 607 surveyed in Senegal expressed willingness to participate in a COVID-19 vaccine trial, with females being more inclined than males. Factors influencing this decision include confidence in the vaccine, health personnel, and government, as well as perceived impact on health from being infected with the coronavirus.